Clinical Trial: Chemoablation for Low-Grade Bladder Cancer

U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07019220) titled 'Chemoablation for Low-Grade Bladder Cancer' on June 04.

Brief Summary: The goal of this single arm, prospective, open-label, investigator-initiated Phase 2 clinical trial is to evaluate the efficacy of intravesical chemoablation in patients with low grade bladder cancer.

Study Start Date: Dec. 27, 2023

Study Type: INTERVENTIONAL

Condition: Bladder (Urothelial, Transitional Cell) Cancer

Intervention: DRUG: Gemcitabine

Intravesical installation

Recruitment Status: RECRUITING

Sponsor: Ekaterina Laukhtina

Information provided by (Responsible Party): Ekaterina Laukhtina, Medical University of Vienna

Disclaimer: Curated by HT S...